![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
CC Chiueh and KE Moore
The lateral and third ventricles of anesthetized cats were perfused continuously with artificial cerebrospinal fluid (CSF) containing 3H- tyrosine and the perfusate was analyzed for 3H-catecholamines. The addition of d-amphetamine sulfate to the perfusing CSF for 2 hours, beginning 2 hours after the start of the 3H-tyrosine perfusion, caused an immediate increase in the efflux of 3H-dopamine. The efflux of this amine declined subsequently despite the continued presence of amphetamine in the CSF. The addition of alpha-methyltyrosine to the CSF concurrently with the d-amphetamine did not markedly alter the immediate increase but accelerated the subsequent decline in the efflux of 3H-dopamine. This suggests that ampetamine initially releases dopamine from a "strong pool," but continuous release is dependent upon ongoing amine synthesis. The addition of d-amphetamine to the 3H- tyrosine containing CSF at the start of perfusion immediately increased the efflux of 3H-dopamine. This response was completely blocked by the presence of alpha-methyltyrosine in the CSF. Pretreatment of cats with reserpine effectively depleted the caudate nucleus of endogenous and 3H- dopamine, but did not alter the ability of d-amphetamine to increase the efflux of 3H-dopamine. Indeed, the amount of 3H-dopamine released during each collection period by either intraventricular or intravenous administration of d-amphetamine was higher than the content of the labeled amine remaining in the whole caudate nucleus. These results suggest that damphetamine can release both "stored" and "newly synthesized" 3H-dopamine from the caudate nucleus, but that the maintenance of the amphetamine-induced release of dopamine is dependent upon the newly synthetized pool.
This article has been cited by other articles:
|
|
 |
|
  R.R. Horsley and H. J. Cassaday Methylphenidate can reduce selectivity in associative learning in an aversive trace conditioning task J Psychopharmacol, July 1, 2007; 21(5): 492 - 500. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Kantor, M. Zhang, B. Guptaroy, Y. H. Park, and M. E. Gnegy Repeated Amphetamine Couples Norepinephrine Transporter and Calcium Channel Activities in PC12 Cells J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1044 - 1051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Kantor, G. H. K. Hewlett, and M. E. Gnegy Enhanced Amphetamine- and K+-Mediated Dopamine Release in Rat Striatum after Repeated Amphetamine: Differential Requirements for Ca2+- and Calmodulin-Dependent Phosphorylation and Synaptic Vesicles J. Neurosci., May 15, 1999; 19(10): 3801 - 3808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Pehek Comparison of Effects of Haloperidol Administration on Amphetamine-Stimulated Dopamine Release in the Rat Medial Prefrontal Cortex and Dorsal Striatum J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 14 - 23. [Abstract] [Full Text]
|
|
|
|
|
|
S. R. Jones, R. R. Gainetdinov, R. M. Wightman, and M. G. Caron Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter J. Neurosci., March 15, 1998; 18(6): 1979 - 1986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Kantor and M. E. Gnegy Protein Kinase C Inhibitors Block Amphetamine-Mediated Dopamine Release in Rat Striatal Slices J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 592 - 598. [Abstract] [Full Text]
|
|
|
|
|
|
E. D. Abercrombie and P. DeBoer Substantia Nigra D1 Receptors and Stimulation of Striatal Cholinergic Interneurons by Dopamine: A Proposed Circuit Mechanism J. Neurosci., November 1, 1997; 17(21): 8498 - 8505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kuczenski, W. P. Melega, A. K. Cho, and D. S. Segal Extracellular Dopamine and Amphetamine After Systemic Amphetamine Administration: Comparison to the Behavioral Response J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 591 - 596. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Breier, T.-P. Su, R. Saunders, R. E. Carson, B. S. Kolachana, A. de Bartolomeis, D. R. Weinberger, N. Weisenfeld, A. K. Malhotra, W. C. Eckelman, et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method PNAS, March 18, 1997; 94(6): 2569 - 2574. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
